This report focuses on the global CAR T-Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
- Celgene (Juno Therapeutics)
- Novartis
- Gilead (Kite Pharma)
- Pfizer
- CARsgen Therapeutics
- Autolus Therapeutics
- Aurora BioPharma
- Sorrento Therapeutics
- Mustang Bio
- Bluebird Bio
- Collectis
- Allogene Therapeutics
- Celyad
Market segment by Type, the product can be split into
- Allogeneic
- Autologous
Market segment by Application, split into
- Hospitals
- Cancer Research Centers
- Others
Market segment by Regions/Countries, this report covers
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
The study objectives of this report are:
- To analyze global CAR T-Cell Therapy status, future forecast, growth opportunity, key market and key players.
- To present the CAR T-Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of CAR T-Cell Therapy are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Allogeneic
1.4.3 Autologous
1.5 Market by Application
1.5.1 Global CAR T-Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the CAR T-Cell Therapy Industry
1.6.1.1 CAR T-Cell Therapy Business Impact Assessment – Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and CAR T-Cell Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for CAR T-Cell Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 CAR T-Cell Therapy Market Perspective (2015-2026)
2.2 CAR T-Cell Therapy Growth Trends by Regions
2.2.1 CAR T-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CAR T-Cell Therapy Historic Market Shar
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Email: help@grandresearchstore.com
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
